A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Pengcheng He, Haibo Liu, Bryan Zimdahl, Jie Wang, Minna Luo, Qi Chang, Fangzhou Tian, Ni Fan, Duo Yu, Huasheng Liu, Li‐Mei Chen, Huaiyu Wang, Mei Zhang, Stephan A. Grupp, Cheng Liu
Topics & Concepts
HematologyRefractory (planetary science)MedicineLymphomaCD19Internal medicineOncologyAntibodyB cellImmunologyCancer researchBiologyAstrobiologyCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchCutaneous lymphoproliferative disorders research